These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7913520)

  • 1. [Limited value of the apomorphine test in Parkinson disease].
    Roos RA; van Laar T; van Hilten JJ
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1374-6. PubMed ID: 7913520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The apomorphine test in Parkinson's disease: diagnostic value].
    Linazasoro G
    Neurologia; 1993 Nov; 8(9):288-90. PubMed ID: 8297620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine test in de novo Parkinson's disease.
    Bonuccelli U; Piccini P; Del Dotto P; Pavese N; D'Antonio P; Muratorio A
    Funct Neurol; 1992; 7(4):295-8. PubMed ID: 1427361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apomorphine in Parkinson disease].
    Gilhus NE
    Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3166-9. PubMed ID: 1948940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine--test in dystonia.
    Langkafel M; Heinz A; Schöls L; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):293-5. PubMed ID: 1685323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine in patients with Parkinson's disease.
    Muguet D; Broussolle E; Chazot G
    Biomed Pharmacother; 1995; 49(4):197-209. PubMed ID: 7669939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apomorphine test in Parkinson disease--dose and corresponding parameters].
    Pinter MM; Helscher RJ; Sattler AP
    Wien Klin Wochenschr; 1993; 105(16):472-5. PubMed ID: 8212705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The apomorphine test for diagnosis of parkinsonian syndrome].
    Piccini P; Del Dotto P; Napolitano A; Pardini C; Bonuccelli U
    Riv Neurol; 1990; 60(6):221-3. PubMed ID: 2100046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.
    Müller T; Benz S; Börnke C; Przuntek H
    Acta Neurol Scand; 2004 May; 109(5):348-54. PubMed ID: 15080862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine test for dopaminergic responsiveness: a dose assessment study.
    Bonuccelli U; Piccini P; Del Dotto P; Rossi G; Corsini GU; Muratorio A
    Mov Disord; 1993 Apr; 8(2):158-64. PubMed ID: 8474482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ; Turner K; Lees AJ
    Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease.
    van Laar T; Neef C; Danhof M; Roon KI; Roos RA
    Mov Disord; 1996 Nov; 11(6):633-8. PubMed ID: 8914088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The apomorphine test in the differential diagnosis of Parkinsonism. Initial experience].
    Roth J; Růzicka E; Mecír P
    Cas Lek Cesk; 1994 Nov; 133(21):665-7. PubMed ID: 7805088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subcutaneous apomorphine infusion in the treatment of Parkinson disease].
    Albani C; Zangger I; Fischer G
    Schweiz Rundsch Med Prax; 1992 Aug; 81(35):1011-5. PubMed ID: 1410978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of apomorphine on the bladder of parkinsonian patients].
    Aranda B; Cramer P; Adba MA
    J Urol (Paris); 1992; 98(1):25-9. PubMed ID: 1527394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcutaneous apomorphine in the treatment of Parkinson's disease].
    Linazasoro G
    Neurologia; 1994 Jan; 9(1):1-3. PubMed ID: 8161461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.